日间手术模式下微创肝切除术的安全性与可行性回顾性研究
结果显示全部手术均无中转开腹,无输血、无Clavien-Dindo≥III级并发症、无再手术或再入院及30天死亡。结论认为MIHAS在高容量微创团队中对经选择患者可安全可行实施。
要点
- 无输血、无主要并发症、无再手术或再入院及30天死亡。
- MIHAS适用于高容量微创团队中的经选择患者。
核心结论
- MIHAS在高容量微创团队中对经选择患者可安全可行地实施。
主要发现
- 10例行左肝外侧叶切除术,19例行肝段切除术,5例行楔形肝切除术。
- 中位手术时间105(89.5,121.5)min,中位估计出血量35(20,50)ml。
- 无患者需要输血,无Clavien-Dindo≥III级主要并发症、肝切除后肝衰竭、术后胆漏或肝切除后出血。
- 无患者需要再手术或再入院,未观察到30天死亡。
临床怎么用
- 在高容量微创团队中,可对经选择的患者尝试开展日间微创肝切除术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ambulatory surgery effectively optimizes the allocation of medical resources and reduces patients' hospitalization time and related costs. Minimally invasive hepatectomy in ambulatory surgery (MIHAS) is rarely reported due to complexity of perioperative management and technical challenges. This study aimed to evaluate safety and feasibility of MIHAS. METHODS: The demographics and short-term outcomes of a consecutive series of patients who underwent MIHAS between July 01, 2024, and January 01, 2025, were analyzed. RESULTS: Thirty-four patients (26 males and eight females, mean age, 56 years). Ten patients underwent left lateral hepatectomy, 19 underwent segmentectomy, and five underwent wedge hepatectomy. All MIHAS procedures were successfully performed without conversion to open surgery. The median operative time was 105 (89.5, 121.5) min, and median estimated blood loss was 35 (20, 50) ml. No patient required a blood transfusion. No patient experienced major postoperative complications (Clavien-Dindo grade ≥ III), post-hepatectomy liver failure, postoperative bile leakage, post-hepatectomy hemorrhage. No patient required reoperation or readmission to the hospital, and no 30-day mortality was observed. CONCLUSION: MIHAS can be safely and feasibly implemented in high-volume minimally invasive teams in selected patients. Further research and more surgical experience are needed to determine the indications for MIHAS.
引用
- Pan LC, Wei YH, Song YY, et al. Minimally invasive hepatectomy in ambulatory surgery: a retrospective study on prospectively collected data in a consecutive patient cohort. Surg Endosc. 2025. PMID: 41361511. doi:10.1007/s00464-025-12458-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。